Genetic Disorder Patients Take Aim At US Over Drug Shortages

Law360, New York (February 22, 2012, 6:47 PM EST) -- More than two dozen people with a rare genetic disorder sued three federal agencies Friday in Washington federal court, saying the government didn't do enough to ensure that Genzyme Corp. maintained adequate drug supplies after a prolonged shortage in medicine used to treat the disease.

The suit, brought by a group of people who have Fabry disease, claims the U.S. Department of Health and Human Services, the U.S. Food and Drug Administration and the National Institutes of Health did not take proper enforcement actions against Genzyme...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.